CellRapeutics™ Leukopak from Endometriosis Donor (XS-0426-XU237)

Name: CellRapeutics™ Leukopak from Endometriosis Donor
SKU: XS-0426-XU237
Rating: 5 (1 reviews)

Online Inquiry Datasheet

All products and services are For Research Use Only and CANNOT be used in the treatment or diagnosis of disease.

Sourced from donors with surgically or clinically diagnosed endometriosis, this Leukopak reflects the unique immunological milieu of this estrogen-dependent inflammatory condition. The collection is enriched with specific NK-cell subsets and myeloid cells involved in ectopic endometrial tissue survival and neuro-angiogenesis. It provides a critical tool for exploring the systemic immune evasion mechanisms that allow for the extrauterine proliferation of endometrial-like stroma and glands.

Specific Inquiry

Add to Cart

Donor Information

Product Name
CellRapeutics™ Leukopak from Endometriosis Donor

Cat. No.
XS-0426-XU237

Donor Age
Young Adult, Middle-Aged

Donor Health
Donors exhibit chronic pelvic inflammatory signatures. The cell population reflects a unique systemic environment with altered NK cell activity and specific angiogenic-supporting monocytic profiles.

Ethnicity
Diverse backgrounds available.

Anticoagulant
Acid Citrate Dextrose, optimized to maintain the viability of angiogenic-related immune subsets and inflammatory cytokine profiles.

Additional Donor Information
Each lot features a Leukopak from donors with laparoscopically confirmed endometriosis. Profiles include disease staging and hormonal treatment history, helping researchers study the role of peripheral immune cells in ectopic endometrial growth.

Clinical Profile
Clinical staging, history of surgical diagnosis or intervention, and current hormonal management.

Additional Information

Medication History
Available upon request. Documentation of hormonal therapies and chronic use of NSAIDs for pain management.

Formulation
Cryopreserved or Fresh options available.

Cell Purity
>90%

Cell Viability
>90%

Mycoplasma Testing
Negative

Sterility Testing
Negative

Genetic Stability Testing
The donor cells maintain their native genetic profile, exhibiting no karyotypic abnormalities or chromosomal instabilities typically associated with prolonged ex vivo expansion.

Application
Drug Discovery, Immuno-oncology Research

Research Use Only
RUO

Quality Control
Each product batch is strictly validated for high cellular viability, specific immune cell counts, and pathogen-free safety, ensuring consistent clinical phenotypes and ethical compliance for advanced immunological research.

Storage
Store fresh Leukopaks at 2°C to 8°C for immediate use, cryopreserved samples must be kept in liquid nitrogen vapor phase below -150°C.

Shiping
Dry Ice

Handling Notes
Process fresh cells within 48 hours or perform rapid thawing of cryovials in a 37°C water bath followed by gradual dilution to maximize recovery.

Warnings
Treat as potentially biohazardous human-derived material and handle strictly under BSL-2 guidelines using appropriate personal protective equipment.

Size
Full Bag, Half Bag

Keywords
CellRapeutics™ Leukopak from Endometriosis Donor, Leukopak, Endometriosis

Case Studies

Customer Reviews and Q&As

There are currently no customer reviews or questions for CellRapeutics™ Leukopak from Endometriosis Donor (XS-0426-XU237). Click the button below to contact us or submit your feedback about this product.

For research use only. Not intended for any clinical use. No products from Creative Biolabs may be resold, modified for resale or used to manufacture commercial products without prior written approval from Creative Biolabs.